There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 62571-86-2 | MDL No. : | |
Formula : | C9H15NO3S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | FAKRSMQSSFJEIM-RQJHMYQMSA-N |
M.W : | 217.29 | Pubchem ID : | 44093 |
Synonyms : |
SQ 14225;SA 333;Captopril, Capoten, SQ14225, SQ 14225, SQ-14225, SQ14,225, SQ 14,225, SQ-14,225
|
Chemical Name : | (S)-1-((S)-3-mercapto-2-methylpropanoyl)pyrrolidine-2-carboxylic acid |
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.78 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 59.97 |
TPSA : | 96.41 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.38 cm/s |
Log Po/w (iLOGP) : | 1.44 |
Log Po/w (XLOGP3) : | 0.34 |
Log Po/w (WLOGP) : | 0.25 |
Log Po/w (MLOGP) : | 0.45 |
Log Po/w (SILICOS-IT) : | 0.61 |
Consensus Log Po/w : | 0.62 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -1.14 |
Solubility : | 15.8 mg/ml ; 0.0729 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.93 |
Solubility : | 2.56 mg/ml ; 0.0118 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.38 |
Solubility : | 91.4 mg/ml ; 0.421 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.47 |
Signal Word: | Danger | Class: | 9 |
Precautionary Statements: | P260-P264-P270-P273-P280-P301+P312+P330-P304+P312-P305+P351+P338-P314-P337+P313-P391-P501 | UN#: | 3077 |
Hazard Statements: | H302-H319-H332-H372-H400 | Packing Group: | Ⅲ |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
30% | With dicyclohexyl-carbodiimide; In dichloromethane; at 0 - 20℃; for 7h; | (1-(3-mercapto-2-methyl-1-oxoprolyl)-2-(oxoethyl-imino-4-bromo)-proline) (2) was synthesized. Captopril with a brominated arm {(1-(3-mercapto-2-methyl-1- oxoprolyl)-2-(oxoethyl-imino-4-bromo)-proline} was synthesized using dicyclohexylcarbodiimide (DCC) activation of carboxylate in <strong>[62571-86-2]captopril</strong> and then coupling with 2-bromo-ethylamine. To a solution (100 mL CH2C12) of 3 g <strong>[62571-86-2]captopril</strong> (14 mmol, 1 equiv. ) cooled in ice, was added 1.88 g 2-bromo-ethylamine (15.2 mmol, 1.1 equiv.) as free base followed by dropwise addition of 2.84 g DCC (14 mmol, 1 equiv. ) over 1 hr. The reaction was stirred for further 6 hr and the precipitated dicyclohexylurea was filtered. Upon solvent evaporation crude product was obtained as a pale yellow solid. The desired product was obtained by flash chromatography (CH3CN, 1st fraction) in 30% yield (1.33 g). MS (electrospray) 345 (M+Na)+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine; In 1,4-dioxane; water; at 0℃; for 4h; | Captopril (2.48 g, 0.0114 Mol) and N, N-diisopropyl ethylamine (4.50 ml, 0.0258 Mol) were dissolved in DIOXANE/H20 (30 ml, 1 : 1). The mixture was cooled to 0C and 1-chloromethyl chloroformate (1.20 ml, 0.0147 Mol) was added. The reaction was stirred at 0C for 4 h, then partitioned between HC1 (4 %, 30 ml) and CH2CL2 (30 ml). The aqueous phase was extracted with CH2C12 (2 x 30 ml) and the combined organic phases were washed with HC1 (4 %, 30 ML) and brine (3 x 30 ml), dried over sodium sulphate and evaporated under reduced pressure affording 1- [ (2S)-3- (chloromethoxycarbonyl) MERCAPTO-2-METHYL-1-OXOPROPYL]-L- proline as a clear oil (2.60 g) that was used without further purification. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With N-ethyl-N,N-diisopropylamine; In water; acetonitrile; at 0 - 20℃; for 4h; | Captopril (3.50 g, 0.0161 Mol) and N, N-diisopropyl ethylamine (6.80 ml, 0.039 Mol) were dissolved in H2O/CH3CN (80 ml, 1: 1) and the mixture was cooled to 0C. Then 4- chlorobutylchloroformate (2.70 ml, 0.0198 Mol) was added and the reaction was slowly warmed to room temperature and stirred for 4 h. The mixture was then partitioned between HC1 (4%, 100 ml) and EtOAc (100 ml). The organic layer was separated and the aqueous phase was extracted with EtOAc (2 x 100 ml). The combined organic phases were washed with brine (3 x 60 ML), dried over sodium sulphate and evaporated under reduced pressure affording 1- [ (2S)-3- (4- chlorobutoxycarbonyl) MERCAPTO-2-METHYL-L-OXOPROPYL]-L- proline (5.90 g) as a colourless oil that was used without further purification. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With sodium nitrite; In hydrogenchloride; | EXAMPLE 2 Preparation of S-Nitroso<strong>[62571-86-2]captopril</strong> 50 mg of Captopril (0.236 mMoles) was dissolved in 10 ml of 0.1 M HCl at room temperature and cooled briefly in an ice bath. A total of 0.25 ml of 1 M NaNO2 was then added in several small portions with rapid swirling. After 2 min on ice, 1.0 ml of 0.5 M Na2 HPO4 was added and the solution was adjusted to pH 7.3 with 0.1 M NaOH. The solution displayed absorption maxima at 542 nm (E=19.8 M-1 cm-1) and 330 nm (E=995 M-1 cm-1). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogenchloride; sodium bicarbonate; In hexane; ethyl acetate; | EXAMPLE 1 5.64 g of 1-(3-bromo-2S-methylpropionyl)-pyrrolidine-2S-carboxylic acid was added to 20 ml of distilled water. While stirring, 1.68 g of sodium hydrogen carbonate and 40 ml of sodium ureido dithiocarbonate solution were added and heated to a temperature between 65 C. and 70 C. and reacted for 5 hours. The reaction mixture was adjusted to a pH value of 1.0 by adding concentrated hydrochloric acid and stirred for another 1 hour and thereafter extracted three times with 50 ml of methylene chloride each time. A yellow syrup was obtained by vacuum distillating the extract. 20 ml of 1N H2 SO4 and 0.2 g of Zinc powder were added to the syrup and vigorously stirred for 2 hours at room temperature. The reaction mixture was extracted three times with 25 ml of ethyl acetate each time and thereafter washed with 30 ml of saturated sodium chloride solution, dried over magnesium sulfate and filtered. The remaining syrup after concentration by vacuum distillation was dissolved in 20 ml of ethyl acetate and subjected to filtration. Hexane was added to the filtrate and the resulting precipitate was filtered and dried at a temperature of 40 C. overnight to obtain 4.0 g of 1-(3-mercapto-2S-methylpropionyl)-pyrrolidine-2S-carboxylic acid as white crystals. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
105 mg (48%) | With 1,8-diazabicyclo[5.4.0]undec-7-ene; N-ethyl-N,N-diisopropylamine; In tetrahydrofuran; | c) Synthesis of N-[(S)-3-hexadecylthio-2-methylpropionyl]proline DIEA (188 mul, 1.10 mmol) was added to a solution of 1-iodohexadecane (176 mg, 0.500 mmol), <strong>[62571-86-2]captopril</strong> (120 mg, 0.550 mmol) and DBU (165 mul, 1.10 mmol) in tetrahydrofuran (5 ml). The mixture was heated at 70 C. for 2 hours and then concentrated. The residue was poured onto water saturated with potassium hydrogen sulphate and organic material was extracted into chloroform. The organic phase was washed with water and dried (MgSO4). The product was purified by chromatography (silica, CHCl3/MeOH/AcOH 85:10:5) and lyophilised to give 105 mg (48%) of white solid material. The structure was verified by 1H (500 Mhz) and 13C (125 Mhz) NMR analysis and further characterised by MALDI mass spectrometry, giving M-H in negative mode at m/z 440 as expected. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
31 - 72% | EXAMPLE1; Allyl bromide (48 ml, 0.556 mol) was added to a solution of anhydrous sodium thiosulfate (88.2 grams, 0.558 mol) in water (189.6 ml), and about one minute thereafter the solution turned yellow. The resulting mixture was then stirred overnight at room temperature and was kept in the cold room (at about 4 0C) for storage. The solution was filtered before usage to remove mechanical impurities. Then, part of this solution (197 ml, 0.4 mol) was transferred to another flask and was mixed with a 0.5 M disodium hydrogen orthophosphate solution (34 ml).In a separate flask, a homogeneous <strong>[62571-86-2]captopril</strong> (CPSH) solution was prepared by dissolving <strong>[62571-86-2]captopril</strong> (21.7 grams, 0.1 mol) in a 0.5 M disodium hydrogen orthophosphate solution (170 ml) while heating the mixture in a water bath under nitrogen atmosphere. The <strong>[62571-86-2]captopril</strong> solution was added to the flask containing the previously prepared allyl thiosulfate solution and stirring was continued under nitrogen atmosphere for 2 hours at room temperature, followed by cooling in an ice bath (to about 5 0C). 4M HCl (15.9 ml) was added to the cooled mixture, so as to acidify the mixture to a final pH of about 3, and a precipitation of a white solid was observed. The mixture was then placed in a cold room (at about 4 C) for 5 days, and <n="23"/>was monitored on a daily basis by HPLC. After 5 days, the precipitate was washed with water, and the crude product was twice slurried in water and filtered. The precipitate was thereafter dried in the air, followed by additional drying in a dessicator over P2O5 under vacuum. The product was then slurried in hexane, and filtered. After drying in a dessicator, pure allyl mercapto<strong>[62571-86-2]captopril</strong> (CPSSA) was obtained (20.87 grams, 0.086 mol, 72 % yield).The purity of the final product, as determined by HPLC, was 99.46 %.1H-NMR (CDCl3): delta = 1.18 (d, 3H), 2.20 (m, 4H), 2.64 (m, IH), 3.03 (m, 2H), 3.29 (d, 2H), 3.64 (t, 2H), 4.55 (m, IH), 5.15 (m, 2H, allyl), 5.80 (m, IH, allyl) ppm. melting point: 44 0C.IR: v = 2968, 1604, 1329, 1187, 924 cm'1.UV-VIS: lambda max = 211 nmThe same experiment was repeated using 128 ml (0.26 mol) of the allyl thiosulfate solution, also obtaining a high purity product (98.74% purity, 17.33 grams, 0.071 mol, 60 % yield).; EXAMPLE 2; Allyl bromide (17.3 ml, 0.2 mol) was added to a solution of sodium thiosulfate pentahydrate (49.6 grams, 0.2 mol) in water (50 ml) and the resulting mixture was stirred at room temperature for 15 hours until the initial two phases disappeared and the reaction mixture became homogeneous. Disodium hydrogen orthophosphate (50 ml of a 0.5 M aqueous solution having a pH of about 8.0) was added and the resulting allyl thiosulfate solution was cooled in an ice bath. A <strong>[62571-86-2]captopril</strong> (CPSH) solution was prepared by dissolving <strong>[62571-86-2]captopril</strong> (32 grams, 0.147 mol) in a 0.5 M disodium hydrogen orthophosphate solution (250 ml) under nitrogen atmosphere. The <strong>[62571-86-2]captopril</strong> solution was added, under stirring and bubbling of nitrogen, to the allyl thiosulfate solution, while maintaining the pH of the reaction mixture at about 8.0. Stirring was continued for 1 hour at 00C and for another hour at room temperature. The reaction mixture was thereafter cooled again in an ice bath, and 4M HCl (35 ml) was added, under nitrogen atmosphere, so as to acidify the mixture to a final pH in the range of 2-3. The mixture was then placed in a <n="24"/>refrigerator (+4 0C) for 4 days, until precipitation of a white solid was observed. The precipitate was filtered, carefully washed with water, and dried under vacuum. The crude product (23 grams) was treated with n-hexane (100 ml) for 1 hour and the white solid was thereafter filtered and dried in vacuum to give pure CPSSA (21 grams, 0.086 mol, 59 % yield).The purity of the final product, as determined by HPLC, was 96 %.1H NMR (CDCl3): delta = 1.18 (d, 3H), 2.20(m, 4H), 2.64(m, IH), 3.03 (m, 2H)5 3.29 (d, 2H), 3.64 (t, 2H), 4.55(m, IH), 5.15(m, 2H allyl), 5.80 (m, IH allyl) ppm. melting point: 44 C. IR: v = 2968, 1604, 1329, 1187, 924 cm"1.UV-vis lambda max = 211 nm.; EXAMPLE 3; Allyl bromide (17.3 ml, 0.2 mol) was added to a solution of sodium thiosulfate pentahydrate (49.6 grams, 0.2 mol) in water (50 ml), and the mixture was stirred at room temperature for 5 hours until the initial two phases disappeared and the reaction mixture became homogeneous. The reaction mixture was then cooled and stirred in an ice bath. A <strong>[62571-86-2]captopril</strong> (CPSH) solution was prepared by dissolving <strong>[62571-86-2]captopril</strong> (32 grams, 0.147 mol) in a 0.5 M disodium hydrogen orthophosphate solution (300 ml) under nitrogen atmosphere. The <strong>[62571-86-2]captopril</strong> solution was added to the reaction mixture, under stirring and bubbling of nitrogen, while maintaining the pH of the reaction mixture at about 8.0 and monitoring the reaction progress by HPLC. Stirring was continued for 30 minutes at 0 0C and the temperature was then raised to room temperature. 4M HCl (35 ml) was added, under nitrogen atmosphere, so as to acidify the mixture to a final pH ... | |
In water; at 0℃; for 0.5 - 0.666667h;pH ~ 8.0;0.5 M disodium hydrogen orthophosphate solution;Product distribution / selectivity; | EXAMPLE 4; Allyl bromide (0.173 ml, 2 mmol) was added to a solution of sodium thiosulfate pentahydrate (500 mg, 2 mmol) in water (5 ml), and the resulting mixture was stirred at room temperature for 15 hours until the initial two phases disappeared and the reaction mixture became homogeneous. The reaction mixture was then cooled and stirred in an ice bath. A <strong>[62571-86-2]captopril</strong> (CPSH) solution was prepared by dissolving <strong>[62571-86-2]captopril</strong> (432 mg, 2 mmol) in 3 ml of a 0.5 M disodium hydrogen orthophosphate solution under nitrogen atmosphere. The <strong>[62571-86-2]captopril</strong> solution was added, under stirring and bubbling of nitrogen, to the allyl thiosulfate mixture, while maintaining the mixture pH at about 8.0. Stirring was continued while monitoring the reaction progress by HPLC. After 30 minutes of stirring at 0 C the reaction mixture contained 70 % of CPSSA and 15 % of unreacted <strong>[62571-86-2]captopril</strong>, as determined by HPLC.; EXAMPLE 5; Allyl chloride (0.144 ml, 2 mmol) was added to sodium thiosulfate pentahydrate (500 mg, 2 mmol) in 5 ml of water, and the mixture was stirred at room temperature for 3 hours until the initial two phases disappeared and the reaction mixture became homogeneous. The reaction mixture was then cooled and stirred in an ice bath. A <strong>[62571-86-2]captopril</strong> (CPSH) solution was prepared by dissolving <strong>[62571-86-2]captopril</strong> (432 mg, 2 mmol) in a 0.5 M disodium hydrogen orthophosphate solution (3 ml) under nitrogen atmosphere. The <strong>[62571-86-2]captopril</strong> solution was added, under stirring and bubbling of nitrogen, to the reaction mixture, while maintaining the pH of the reaction mixture at about 8.0. Stirring was continues while monitoring the reaction progress by HPLC. <n="26"/>After 40 minutes of stirring at 0 0C, the reaction mixture contained 30 % of CPSSA and 20 % unreacted <strong>[62571-86-2]captopril</strong>, as well as other products, as determined by HPLC.; EXAMPLE 6; AHyI chloride (0.720 ml, 10 mmol) was added to a solution of sodium thiosulfate pentahydrate (2.48 grams, 10 mmol) in water (15 ml), and the resulting mixture was stirred at room temperature for 15 hours until the initial two phases disappeared and the reaction mixture became homogeneous. The water was thereafter evaporated in vacuum and the precipitated white solid (1.76 grams) was washed with ethyl alcohol, dried and re-dissolved in a 0.5 M disodium hydrogen orthophosphate buffer (10 ml). The mixture was cooled and stirred in ice bath. A <strong>[62571-86-2]captopril</strong> (CPSH) solution was prepared by dissolving <strong>[62571-86-2]captopril</strong> (920 mg, 4.2 mmol) in a 0.5 M disodium hydrogen orthophosphate solution (3 ml) under nitrogen atmosphere. The <strong>[62571-86-2]captopril</strong> solution was added, under stirring and bubbling of nitrogen, to the allyl thiosulfate mixture, while maintaining the pH of the reaction mixture at about 8.0. Stirring was continues while monitoring the reaction progress by HPLC. After 30 minutes of stirring at 0 C, the reaction mixture contained 38 % of CPSSA and 43 % unreacted <strong>[62571-86-2]captopril</strong>, as determined by HPLC. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
50% | With thionyl chloride; at 0 - 60℃; for 7h; | To (9.21 mmol, 2.0 g) of cold <strong>[62571-86-2]captopril</strong> solution in (20 ml) methanol, (9.21 mmol, 1.8 ml) of thionyl chloride (SOCl2), was added via dropping funnel, over 30 min. The temperature was maintained at 0C for 1h. The mixture was stirred for 2 h, at r. t and then, 4h at 50-60C. Excess of solvent and (SOCl2) was removed by rotary evaporator. The product was re-dissolved in (20 ml) ethyl acetate, and extracted with 5% sodium bicarbonate and water (3x20ml), respectively. The organic layer was dried over anhydrous MgSO4, and left the solvent to evaporate.Colourless oil, yield 50%., B.P 75OC, Rf = 0.5, IR (KBr disc, v= cm-1): 2972.31 and 2875.86 (CH) str of aliph. CH2 & CH3; 2549.89 (SH) str of thiol; 1732.08 (C=O) str of ester; 1639.49 (C=O) str of amide of pyrrolidine; 1172.08 asym str (C-O-C); 1043.43 sym (C-O-C) str of OCH3. Colourless oil, yield 50%., B.P 75C, Rf = 0.5, IR (KBr disc, v= cm-1): 2972.31 and 2875.86 (CH) str of aliph. CH2 & CH3; 2549.89 (SH) str of thiol; 1732.08 (C=O) str of ester; 1639.49 (C=O) str of amide of pyrrolidine; 1172.08 asym str (C-O-C); 1043.43 sym (C-O-C) str of OCH3. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
N-Boc alanine (10 G, 0.0528 Mol) and carbonyldiimidazole (10.3 g, 0.0634 Mol) were dissolved in THF (100ML) and stirred overnight at room temperature. Then TEA was added (7.4 ML. 0.0528 Mol) and to this reaction mixture a solution of <strong>[62571-86-2]captopril</strong> (11.5 g, 0.0528 Mol) in THF (20ML) was added dropwise and the reaction was stirred overnight at room temperature. The mixture was then partitioned between KHS04 10% and EtOAc (120 ml). The organic layer was separated and the aqueous phase was extracted with EtOAc (2 x 60 ml). The combined organic phases were washed with water (3 x 60 ml), dried over sodium sulphate and evaporated under reduced pressure affording 16 g of L-N-BOC-ALANYL- (2S)-3-MERCAPTO-2- METHYLPROPANOYL-L-PROLINE as a white solid. 1H-NMR (CDC13) : (2 rotamers) 5.05 (BD, 1H), 4.90 (BD, 1H), 4.60 (m, 1H), 4.45 (m, 1H), 4.30 (m, 1H), 3.55 (m, 2H), 3.1 and 2.9 (m, 3H), 2.5 (m, 1H), 2.05 (m, 3H), 1.47 (s, 9H), 1. 4 (d, 3H), 1.25 (d, 3H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
A-CHLORO-TOLUIC acid (9.0 g, 0.0528 Mol) and carbonyldiimidazole (10.3 g, 0.0634 Mol) were dissolved in THF (100ML) and stirred overnight at room temperature. Then TEA was added (7.4 ml. 0.0528 Mol) and to this reaction mixture a solution of <strong>[62571-86-2]captopril</strong> (11.5 g, 0.0528 Mol) in THF (20ML) was added dropwise and the reaction was stirred overnight at room temperature. The mixture was then partitioned between KHS04 10% and EtOAc (120 ml). The organic layer was separated and the aqueous phase was extracted with EtOAc (2 x 60 ML). The combined organic phases were washed with water (3 x 60 ml), dried over sodium sulphate and evaporated under reduced pressure affording 14.1 G of 1- [ (2S)-3- (4- chloromethylbenzoyl) MERCAPTO-2-METHYL-1-OXOPROPYL]-L- proline as a white solid used for the next step without further purification. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
20% | With zinc(II) sulfate heptahydrate; In water; at 87℃; for 24h;Autoclave; High pressure; | The <strong>[62571-86-2]captopril</strong> disulphide compound was synthesised under hydrothermal conditions. Approximately 8 ml of an aqueous solution containing <strong>[62571-86-2]captopril</strong> (0.23 mmol) was added to 8 ml of an aqueous solution containing ZnSO4*7H2O (0.11 mmol). This mixture was transferred toa 23-ml Teflon-lined Parr acid digestion bomb. The reaction vessel was heated at 87C for 24 h, and after this time, it was slowly cooled to 25C. The resulting clear solution was transferred to a beaker and set aside. After 7 days, colourless crystals suitable for the X-ray diffraction analysis formed with a yield of 20%. The elemental analysis indicated C18H28N2O6S2: calcd.(%): C 49.98, H 6.52, N 6.48; found (%): C 50.03, H 6.55, N 6.43. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
96% | In water; N,N-dimethyl-formamide; for 0.5h; | KSH-1 (1) (410 mg, 0.145 mmol, 4 equiv from <strong>[62571-86-2]captopril</strong>) was poured into a filtration tube. A solution of <strong>[62571-86-2]captopril</strong> (11) (7.89 mg, 36.3 mumol) in DMF/water = 1/1 (7 mL) was added and the solution was stirred for 30 min. The reaction mixture was analyzed by reverse-phase HPLC. After the disappearance of the <strong>[62571-86-2]captopril</strong> peak, solutions were separated from the resin by filtration. The resin was washed away using DMF, and the collected filtrate was concentrated in vacuo. The resultant residue was co-evaporated with water and ethanol after drying under reduced pressure to give the biotin-labeled <strong>[62571-86-2]captopril</strong> 12 (18.0 mg, 96%) as a colorless solid; (12 was dissolved in 15% aqueous MeOH and analyzed by reverse-phase HPLC. The purity of 12 was 87%.). 1H NMR (400 MHz, CD3OD) delta 1.21 (d, J = 6.8 Hz, 2H), 1.28-1.81 (m, 6H), 1.98-2.14 (m, 3H), 2.16-2.41 (m, 3H), 2.66-2.76 (m, 2H), 2.76-2.89 (m, 1H), 2.89-3.06 (m, 2H), 3.08-3.25 (m, 3H), 3.38-3.54 (m, 2H), 3.60-3.80 (m, 2H), 4.26-4.35 (m, 1H), 4.37-4.46 (m, 1H), 4.46-4.54 (m, 1H); HRMS (ES+): m/z 519.1745 (M+H+) (calcd for C21H35N4O5S3: 519.1770). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
76.3% | With potassium carbonate; In dimethyl sulfoxide; at 20℃; for 48h;Inert atmosphere; | Captopril phthalonitrile (4) was synthesized as follows: to dry DMSO (10 ml) under nitrogen atmosphere, <strong>[62571-86-2]captopril</strong> (0.8 g, 3.68 mmol) and 4-nitrophthalonitrile (3a, 1 g, 5.78 mmol) were added and the mixture left to stir for 15 min. K2CO3 (2.5 g, 18.09 mmol) was added to the mixture over 2 h. The mixture was stirred for a total of 48 h at room temperature. After 48 h, the product formed was precipitated out by acetone, filtered and air dried. Yield: 76.3%. IR [(KBr) numax/cm-1]: 2235 (C-N), 700 (C-S-C), 2921 (S-C), 3440 (O-H). 1H NMR (D2O): delta, ppm 8.32 (1H, s, Ar-H), 8.25 (1H, d, Ar-H), 7.60 (1H, m, Ar-H), 2.87-4.10 (3H, m, N-CH2, CH), 1.50-2.92 (7H, m, CH2, S-CH2), 1.08 (3H, m, CH3). 13C NMR (D2O with a drop of MeOD): delta, ppm 175.1 (C=O), 169.8 (C=O), 142.2 (Ar-S), 135.3 (Ar-C), 124.0 (Ar-C), 123.9 (Ar-C), 121.2 (Ar-CN), 119.8 (Ar-CN), 118.6 (CN), 118.1 (CN) 57.1 (N-CH), 43.3 (N-CH2), 35.8 (CH), 32.6 (S-CH2), 26.8 (CH2), 24.9 (CH2), 19.8 (CH3). ESI-MS m/z: Calcd: 343. Found: [M]- 343. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
503.9 mg | With triethylamine; In dichloromethane; at -5 - 20℃; for 4.5h;pH 8-9; | Dry <strong>[62571-86-2]captopril</strong> (0.87 g)And dichloromethane (15 ml)In a dry crystallized 250 ml three-necked round bottom flask,After stirring in an ice bath (-5-0 C) for 0.5h, acetyl chloride (0.35ml)The pH was adjusted to 8-9 with triethylamine (TEA)Reaction at room temperature 4h.After the reaction was filtered, add 0.1M / L dilute HCl extraction,Then dried over anhydrous sodium sulfate, filtered,The filtrate was evaporated in vacuo to give the product as a white solid.This product (503.9 mg)And nornithium trisulfide (0.91 mg)In a solvent of dichloromethane (12 ml)The reaction at room temperature 24h, the reaction was terminated.The mixture was extracted with hydrochloric acid and dichloromethane. The supernatant was extracted with saturated sodium chloride solution and adjusted to neutral. The supernatant was removed by adding anhydrous sodium sulphate and filtered. The residue was rotary evaporated (40 C)The product was dried in vacuo (0.12 g). Yield: 59.8%. |
Tags: 62571-86-2 synthesis path| 62571-86-2 SDS| 62571-86-2 COA| 62571-86-2 purity| 62571-86-2 application| 62571-86-2 NMR| 62571-86-2 COA| 62571-86-2 structure
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :